Full name
LABORATORIUM FARMACEUTYCZNE AVENA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
46.76.Z - Wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 9,4 | 10,3 | 10,2 | -0,1 |
Gross profit (loss) | 1,5 | 2,3 | 0,7 | -68,4 |
EBITDA | 1,6 | 2,3 | 0,7 | -71,1 |
Net profit (loss) | 1,2 | 1,9 | 0,6 | -68,9 |
Cash | 0,3 | 3,7 | 5 | 33,8 |
Net income from sale | 7,9 | 9,4 | 7,5 | -20 |
Liabilities and provisions for liabilities | 2,4 | 1,2 | 0,6 | -45,8 |
Short time liabilities | 1,4 | 1,2 | 0,6 | -45,8 |
Equity capital | 7 | 9,1 | 9,6 | 5,7 |
Working assets | 6,1 | 6,8 | 7,5 | 10,3 |
Operating profit (EBIT) | 1,5 | 2,3 | 0,6 | -73 |
Depreciation | 0,1 | 0,1 | 0,1 | -13,3 |
% | % | % | p.p. | |
Profitability of capital | 16,8 | 20,7 | 6,1 | -14,6 |
Equity capital to total assets | 74,3 | 88,7 | 93,9 | 5,2 |
Gross profit margin | 18,3 | 24,7 | 9,8 | -14,9 |
EBITDA Margin | 20 | 24,7 | 8,9 | -15,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 63 | 45 | 30 | -15 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane